Pyridoxine


Generic Medicine Info
Administration
May be taken with or without food. Best taken w/ food & liqd. Consult product literature for specific instructions. ER tab: Swallow whole, do not break/crush/chew.
Special Precautions
Children. Pregnancy and lactation. Patient counselling If you develop tingling, burning, or numbness in the hands or feet during treatment, inform your doctor immediately. Monitoring Parameters Closely monitor for signs and symptoms of peripheral neuropathy. Consider performing nerve conduction velocity tests every 1-2 years in patients receiving long-term higher doses.
Adverse Reactions
Significant: Severe peripheral neuropathies, particularly during long-term use and/or use of high doses (risk may vary between individuals; there have been reported cases of peripheral neuropathy even with doses <50 mg/day); drug dependence and withdrawal (for doses ≥200 mg/day). Gastrointestinal disorders: Nausea. Immune system disorders: Hypersensitivity reaction. Investigations: Increased serum AST, decreased serum folic acid levels. Metabolism and nutrition disorders: Metabolic acidosis (particularly in patients with seizures following rapid infusion of high doses). Nervous system disorders: Headache, paraesthesia, drowsiness; seizure (very high IV doses).
Drug Interactions
May reduce the serum levels of phenobarbital and phenytoin. May reduce the effect of levodopa (when concurrently used without a dopa-decarboxylase inhibitor) and altretamine. Oral contraceptives (e.g. estrogen), cycloserine, penicillamine, isoniazid and hydralazine may increase the requirements for pyridoxine.
CIMS Class
Vitamin B-Complex / with C
Disclaimer: This information is independently developed by CIMS based on pyridoxine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in